RMA
GHSI

Roffman Miller Associates’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Roffman Miller Associates’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40
Closed -$311 – 166
2023
Q2 		$311 Buy
+40
New +$251 ﹤0.01% 159

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Roffman Miller Associates's GHSI Position: Q3 2023 in Review

Roffman Miller Associates sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q3 2023, closing a stake of 40 shares — an estimated $311 sold.

Roffman Miller Associates first reported a position in GHSI in Q2 2023 and held it in 1 quarter. The position peaked at $311 in Q2 2023. 14 funds tracked by Wall St. Rank hold GHSI as of Q3 2023.

  • Roffman Miller Associates reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Roffman Miller Associates sold 40 Guardion Health Sciences, Inc. Common Stock shares in Q3 2023, an estimated $311.
  • Roffman Miller Associates first reported a position in Guardion Health Sciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Roffman Miller Associates's Guardion Health Sciences, Inc. Common Stock position peaked at $311 in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q3 2023.

Based on Roffman Miller Associates's 13F filing for Q3 2023, filed 9 Nov 2023.